The Gross Margin of Endonovo Therapeutics Inc (ENDV) is 92.62%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2022-12-31 | 92.62% |
2021-12-31 | 79.50% |
2020-12-31 | 60.57% |
2019-12-31 | 69.89% |
2018-12-31 | 84.47% |
2017-12-31 | 49.41% |
2016-12-31 | 35.97% |
2015-12-31 | 38.91% |